Proteases involved in cartilage matrix degradation in osteoarthritis.

Osteoarthritis is a common joint disease for which there are currently no disease-modifying drugs available. Degradation of the cartilage extracellular matrix is a central feature of the disease and is widely thought to be mediated by proteinases that degrade structural components of the matrix, primarily aggrecan and collagen. Studies on transgenic mice have confirmed the central role of Adamalysin with Thrombospondin Motifs 5 (ADAMTS-5) in aggrecan degradation, and the collagenolytic matrix metalloproteinase MMP-13 in collagen degradation. This review discusses recent advances in current understanding of the mechanisms regulating expression of these key enzymes, as well as reviewing the roles of other proteinases in cartilage destruction. This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.

[1]  R. Khokha,et al.  Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  J. Pelletier,et al.  Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study , 2007, Arthritis research & therapy.

[3]  M. Adams,et al.  Increased apoptosis in human osteoarthritic cartilage corresponds to reduced cell density and expression of caspase-3. , 2004, Arthritis and rheumatism.

[4]  E. Radisky Cathepsin D , 2010, Cancer biology & therapy.

[5]  Z. Werb,et al.  Cloning and Characterization of Two Extracellular Heparin-degrading Endosulfatases in Mice and Humans* , 2002, The Journal of Biological Chemistry.

[6]  J. Pelletier,et al.  Collagenase 3 production by human osteoarthritic chondrocytes in response to growth factors and cytokines is a function of the physiologic state of the cells. , 1999, Arthritis and rheumatism.

[7]  K. Yudoh,et al.  Expression of proteinase-activated receptors (PAR)-2 in articular chondrocytes is modulated by IL-1β, TNF-α and TGF-β , 2006 .

[8]  A. Cole,et al.  Characterization of TIMP-3 in human articular talar cartilage , 2010, Connective tissue research.

[9]  Martin Michaelis,et al.  Osteoarthritis — an untreatable disease? , 2005, Nature Reviews Drug Discovery.

[10]  C. Southan,et al.  The HtrA family of proteases: implications for protein composition and cell fate. , 2002, Molecular cell.

[11]  D. D’Lima,et al.  Expression of novel extracellular sulfatases Sulf-1 and Sulf-2 in normal and osteoarthritic articular cartilage , 2008, Arthritis research & therapy.

[12]  J. Pujol,et al.  Semiquantitative reverse transcription-polymerase chain reaction analysis of syndecan-1 and -4 messages in cartilage and cultured chondrocytes from osteoarthritic joints. , 2000, Osteoarthritis and cartilage.

[13]  J. Sandy,et al.  A contentious issue finds some clarity: on the independent and complementary roles of aggrecanase activity and MMP activity in human joint aggrecanolysis. , 2006, Osteoarthritis and cartilage.

[14]  G. Yancopoulos,et al.  An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. , 1997, Molecular cell.

[15]  K. Matsushima,et al.  Molecular Cloning of a Gene Encoding a New Type of Metalloproteinase-disintegrin Family Protein with Thrombospondin Motifs as an Inflammation Associated Gene* , 1997, The Journal of Biological Chemistry.

[16]  K. Brew,et al.  The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. , 2010, Biochimica et biophysica acta.

[17]  Johanne Martel-Pelletier,et al.  Role of proinflammatory cytokines in the pathophysiology of osteoarthritis , 2011, Nature Reviews Rheumatology.

[18]  Brendan H. Lee,et al.  Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte–specific expression in vivo , 2003, The Journal of cell biology.

[19]  R. Altman,et al.  Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis. , 2002, Arthritis and rheumatism.

[20]  E. Vuorio,et al.  Spontaneous development of synovitis and cartilage degeneration in transgenic mice overexpressing cathepsin K. , 2005, Arthritis and rheumatism.

[21]  A. Fosang,et al.  ADAMTS-5: the story so far. , 2008, European cells & materials.

[22]  K. Malizos,et al.  Low‐density lipoprotein receptor‐related protein 5 (LRP5) expression in human osteoarthritic chondrocytes , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[23]  C. L. Murphy,et al.  Hypoxia-inducible factor 2alpha is essential for hypoxic induction of the human articular chondrocyte phenotype. , 2007, Arthritis and rheumatism.

[24]  Yefu Li,et al.  Role of HTRA1, a serine protease, in the progression of articular cartilage degeneration. , 2010, Histology and histopathology.

[25]  Klaus Ersfeld,et al.  The calpains: modular designs and functional diversity , 2007, Genome Biology.

[26]  Kozo Nakamura,et al.  Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. , 2006, Arthritis and rheumatism.

[27]  Je-Yong Choi,et al.  Analysis of the Runx2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator. , 2008, Gene.

[28]  M. Kashiwagi,et al.  TIMP‐3 inhibits aggrecanase‐mediated glycosaminoglycan release from cartilage explants stimulated by catabolic factors , 2003, FEBS letters.

[29]  Dean M. Messing,et al.  Cartilage degradation biomarkers predict efficacy of a novel, highly selective matrix metalloproteinase 13 inhibitor in a dog model of osteoarthritis: confirmation by multivariate analysis that modulation of type II collagen and aggrecan degradation peptides parallels pathologic changes. , 2010, Arthritis and rheumatism.

[30]  T. Matsushita,et al.  SIRT1 regulation of apoptosis of human chondrocytes. , 2009, Arthritis and rheumatism.

[31]  T. Hardingham,et al.  Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins. , 1991, The Journal of biological chemistry.

[32]  K. Shimizu,et al.  Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain. , 2004, The Biochemical journal.

[33]  R. Magolda,et al.  Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors. , 2001, Journal of medicinal chemistry.

[34]  J. Saklatvala,et al.  Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. , 2009, Arthritis and rheumatism.

[35]  Margaret M. Smith,et al.  Activation of cartilage matrix metalloproteinases by activated protein C. , 2009, Arthritis and rheumatism.

[36]  T. Aigner,et al.  Up-regulation of MDC15 (metargidin) messenger RNA in human osteoarthritic cartilage. , 1999, Arthritis and rheumatism.

[37]  M. Bayliss,et al.  Studies on cathepsin B in human articular cartilage. , 1978, The Biochemical journal.

[38]  J. Enghild,et al.  Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications , 2010, The Biochemical journal.

[39]  E. Lavallie,et al.  Identification of a Novel HtrA1-susceptible Cleavage Site in Human Aggrecan , 2009, The Journal of Biological Chemistry.

[40]  S. Santavirta,et al.  Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis. , 2002, Arthritis and rheumatism.

[41]  R. Copeland,et al.  Aggrecan Protects Cartilage Collagen from Proteolytic Cleavage* , 2003, Journal of Biological Chemistry.

[42]  C. Little,et al.  ADAMTS-1-knockout mice do not exhibit abnormalities in aggrecan turnover in vitro or in vivo. , 2005, Arthritis and rheumatism.

[43]  A. Poole,et al.  The capacity of pig articular cartilage in organ culture to regenerate after breakdown induced by complement-sufficient antiserum to pig erythrocytes , 1976, Calcified Tissue Research.

[44]  F. Navarro-Garcia,et al.  Cell death of chondrocytes is a combination between apoptosis and autophagy during the pathogenesis of Osteoarthritis within an experimental model , 2010, Apoptosis.

[45]  G. Weissmann,et al.  Comparison of the effects of papain n vitamin A on cartilage. I. The effects in rabbits. , 1960 .

[46]  B. Alman,et al.  Modulating hedgehog signaling can attenuate the severity of osteoarthritis , 2009, Nature Medicine.

[47]  C. Little,et al.  Low molecular weight isoforms of the aggrecanases are responsible for the cytokine-induced proteolysis of aggrecan in a porcine chondrocyte culture system. , 2007, Arthritis and rheumatism.

[48]  R. Leduc,et al.  Characterization of proADAMTS5 processing by proprotein convertases. , 2009, The international journal of biochemistry & cell biology.

[49]  L. Lohmander,et al.  The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. , 1992, The Journal of clinical investigation.

[50]  T. Ochi,et al.  Novel mutations of the cathepsin K gene in patients with pycnodysostosis and their characterization. , 2000, The Journal of clinical endocrinology and metabolism.

[51]  Z. Werb,et al.  HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1 , 2006, BMC Biochemistry.

[52]  A. Struglics,et al.  Calpain Is Involved In C-Terminal Truncation Of Human Aggrecan , 2010 .

[53]  R. Leduc,et al.  Characterization of ADAMTS-9 and ADAMTS-20 as a Distinct ADAMTS Subfamily Related to Caenorhabditis elegans GON-1* , 2003, The Journal of Biological Chemistry.

[54]  Li-li Feng Wnt/ beta -Catenin Signaling in the Pathogenesis of Osteoarthritis , 2011 .

[55]  F. Voss,et al.  MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. , 2010, Arthritis and rheumatism.

[56]  R. Khokha,et al.  Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice. , 2007, Arthritis and rheumatism.

[57]  M. Feldmann,et al.  Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics , 2008, Immunological reviews.

[58]  W. Parks,et al.  Control of matrix metalloproteinase catalytic activity. , 2007, Matrix biology : journal of the International Society for Matrix Biology.

[59]  G. Thomas,et al.  Furin at the cutting edge: From protein traffic to embryogenesis and disease , 2002, Nature Reviews Molecular Cell Biology.

[60]  N. Sang,et al.  Histone Deacetylase Inhibitors Repress the Transactivation Potential of Hypoxia-inducible Factors Independently of Direct Acetylation of HIF-α* , 2006, Journal of Biological Chemistry.

[61]  R. Wynn,et al.  Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. , 1999, Science.

[62]  Lewis Thomas,et al.  REVERSIBLE COLLAPSE OF RABBIT EARS AFTER INTRAVENOUS PAPAIN, AND PREVENTION OF RECOVERY BY CORTISONE , 1956, The Journal of experimental medicine.

[63]  R. D. Dyer,et al.  Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects* , 2007, Journal of Biological Chemistry.

[64]  D. Essex,et al.  Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[65]  D. Griggs,et al.  ADAM-8 isolated from human osteoarthritic chondrocytes cleaves fibronectin at Ala(271). , 2009, Arthritis and rheumatism.

[66]  F Eckstein,et al.  Knee cartilage of spinal cord-injured patients displays progressive thinning in the absence of normal joint loading and movement. , 2002, Arthritis and rheumatism.

[67]  T. Bugge,et al.  Type II Transmembrane Serine Proteases* , 2009, The Journal of Biological Chemistry.

[68]  D. Heinegård,et al.  The role of the cartilage matrix in osteoarthritis , 2011, Nature Reviews Rheumatology.

[69]  A. Rowan,et al.  Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis , 2006, Arthritis research & therapy.

[70]  Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis , 2010, Modern rheumatology.

[71]  K. Tanaka,et al.  Extracellular appearance of calpain and calpastatin in the synovial fluid of the knee joint. , 1989, Biochemical and biophysical research communications.

[72]  R. Tuan,et al.  Inhibition of histone deacetylases antagonized FGF2 and IL-1β effects on MMP expression in human articular chondrocytes , 2009, Growth factors.

[73]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[74]  X. Puente,et al.  Degradome expression profiling in human articular cartilage , 2009, Arthritis research & therapy.

[75]  A. Fourie,et al.  ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro , 2005, Nature.

[76]  Gakuji Hashimotoa,et al.  Inhibition of ADAMTS 4 ( aggrecanase-1 ) by tissue inhibitors of metalloproteinases ( TIMP-1 , 2 , 3 and 4 ) , 2001 .

[77]  J. Sandy,et al.  ADAMTS4 (Aggrecanase-1) Activation on the Cell Surface Involves C-terminal Cleavage by Glycosylphosphatidyl Inositol-anchored Membrane Type 4-Matrix Metalloproteinase and Binding of the Activated Proteinase to Chondroitin Sulfate and Heparan Sulfate on Syndecan-1* , 2004, Journal of Biological Chemistry.

[78]  R. Tuan,et al.  Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. , 2004, Osteoarthritis and cartilage.

[79]  J. Beckwith,et al.  An Escherichia coli mutation preventing degradation of abnormal periplasmic proteins. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[80]  A. Rowan,et al.  Inhibition of furin-like enzymes blocks interleukin-1alpha/oncostatin M-stimulated cartilage degradation. , 2003, Arthritis and rheumatism.

[81]  Yeong-Wook Song,et al.  Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis , 2009, Nature Medicine.

[82]  M. Hurtig,et al.  OP-1/BMP-7 in cartilage repair , 2007, International Orthopaedics.

[83]  E. Lavallie,et al.  Autocatalytic Cleavage of ADAMTS-4 (Aggrecanase-1) Reveals Multiple Glycosaminoglycan-binding Sites* , 2002, The Journal of Biological Chemistry.

[84]  T. Pawson,et al.  The discoidin domain receptor tyrosine kinases are activated by collagen. , 1997, Molecular cell.

[85]  S Foundling,et al.  The 2.8 A crystal structure of Gla‐domainless activated protein C. , 1996, The EMBO journal.

[86]  Rebecca C Taylor,et al.  Apoptosis: controlled demolition at the cellular level , 2008, Nature Reviews Molecular Cell Biology.

[87]  D. Hall,et al.  A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage‐specific genes in human chondrocytes , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[88]  W. Ferrell,et al.  Matriptase is a novel initiator of cartilage matrix degradation in osteoarthritis. , 2010, Arthritis and rheumatism.

[89]  A. V. van Kuilenburg,et al.  Histone deacetylases (HDACs): characterization of the classical HDAC family. , 2003, The Biochemical journal.

[90]  J. Lucy,et al.  STUDIES ON THE MODE OF ACTION OF EXCESS OF VITAMIN A , 1963, The Journal of cell biology.

[91]  Jonghwan Kim,et al.  Hypoxia-inducible factor-2α is a catabolic regulator of osteoarthritic cartilage destruction , 2010, Nature Medicine.

[92]  C. Rorabeck,et al.  Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. , 1997, The Journal of clinical investigation.

[93]  R. Dickson,et al.  Matriptase activates stromelysin (MMP‐3) and promotes tumor growth and angiogenesis , 2006, Cancer science.

[94]  M Kashiwagi,et al.  TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)* , 2001, The Journal of Biological Chemistry.

[95]  A. Barrett,et al.  Evidence that extracellular cathepsin D is not responsible for the resorption of cartilage matrix in culture. , 1982, Biochimica et biophysica acta.

[96]  Y. Pei,et al.  Characterization of the human ADAMTS-5 (aggrecanase-2) gene promoter , 2007, Molecular Biology Reports.

[97]  J. Woessner,et al.  Purification of the neutral proteoglycan-degrading metalloproteinase from human articular cartilage tissue and its identification as stromelysin matrix metalloproteinase-3. , 1989, The Biochemical journal.

[98]  Chris Davies,et al.  The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis. , 2011, Bioorganic & medicinal chemistry letters.

[99]  Li-Dong Wu,et al.  The emerging role of adipokines in osteoarthritis: a narrative review , 2011, Molecular Biology Reports.

[100]  S. Goldring,et al.  Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis , 2010, Annals of the New York Academy of Sciences.

[101]  S. Takada,et al.  MicroRNA-140 plays dual roles in both cartilage development and homeostasis. , 2010, Genes & development.

[102]  T. Spector,et al.  Association of a nsSNP in ADAMTS14 to some osteoarthritis phenotypes. , 2009, Osteoarthritis and cartilage.

[103]  D. Zukor,et al.  Cleavage of type II collagen by cathepsin K in human osteoarthritic cartilage. , 2008, The American journal of pathology.

[104]  J. Pelletier,et al.  Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage. , 1991, The Journal of rheumatology.

[105]  Y. Ouchi,et al.  Association of a single nucleotide polymorphism in the WISP1 gene with spinal osteoarthritis in postmenopausal Japanese women , 2007, Journal of Bone and Mineral Metabolism.

[106]  V. Quesada,et al.  Identification and Enzymatic Characterization of Two Diverging Murine Counterparts of Human Interstitial Collagenase (MMP-1) Expressed at Sites of Embryo Implantation* , 2001, The Journal of Biological Chemistry.

[107]  C. Little,et al.  Is cartilage matrix breakdown an appropriate therapeutic target in osteoarthritis--insights from studies of aggrecan and collagen proteolysis? , 2010, Current drug targets.

[108]  D. Brömme,et al.  Cleavage Site Specificity of Cathepsin K toward Cartilage Proteoglycans and Protease Complex Formation , 2003, Biological chemistry.

[109]  J. Enghild,et al.  Altered Proteolytic Activities of ADAMTS-4 Expressed by C-terminal Processing* , 2004, Journal of Biological Chemistry.

[110]  I. Otterness,et al.  Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[111]  S. Apte A Disintegrin-like and Metalloprotease (Reprolysin-type) with Thrombospondin Type 1 Motif (ADAMTS) Superfamily: Functions and Mechanisms* , 2009, The Journal of Biological Chemistry.

[112]  J. Saklatvala,et al.  FGF-2 is bound to perlecan in the pericellular matrix of articular cartilage, where it acts as a chondrocyte mechanotransducer. , 2007, Osteoarthritis and cartilage.

[113]  Claus Christiansen,et al.  Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity , 2008, Arthritis research & therapy.

[114]  C. López-Otín,et al.  Collagenase 3 Is a Target of Cbfa1, a Transcription Factor of the runt Gene Family Involved in Bone Formation , 1999, Molecular and Cellular Biology.

[115]  K. Brew,et al.  TIMP-3 Binds to Sulfated Glycosaminoglycans of the Extracellular Matrix* , 2000, The Journal of Biological Chemistry.

[116]  T. Yamamuro,et al.  Biochemical demonstration of calpains and calpastatin in osteoarthritic synovial fluid. , 1990, Arthritis and rheumatism.

[117]  K. Yudoh,et al.  Expression of proteinase-activated receptors (PAR)-2 in articular chondrocytes is modulated by IL-1beta, TNF-alpha and TGF-beta. , 2006, Osteoarthritis and cartilage.

[118]  H. Sun,et al.  Physiological loading of joints prevents cartilage degradation through CITED2 , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[119]  J. Lucy,et al.  Studies on the mode of action of excess of vitamin A. 2. A possible role of intracellular proteases in the degradation of cartilage matrix. , 1961, The Biochemical journal.

[120]  K. Matsushima,et al.  ADAMTS‐1 cleaves a cartilage proteoglycan, aggrecan , 2000, FEBS letters.

[121]  T. Hardingham,et al.  Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. , 1993, The Biochemical journal.

[122]  A. Poole,et al.  Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. , 2001, The Journal of clinical investigation.

[123]  J. Kumm,et al.  Association of ADAM12-S protein with radiographic features of knee osteoarthritis and bone and cartilage markers , 2012, Rheumatology International.

[124]  A. Grodzinsky,et al.  Co-culture of mechanically injured cartilage with joint capsule tissue alters chondrocyte expression patterns and increases ADAMTS5 production. , 2009, Archives of biochemistry and biophysics.

[125]  D. Hall,et al.  Regulation of Cartilage-specific Gene Expression in Human Chondrocytes by SirT1 and Nicotinamide Phosphoribosyltransferase* , 2008, Journal of Biological Chemistry.

[126]  R. Wait,et al.  Basic FGF mediates an immediate response of articular cartilage to mechanical injury , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[127]  R. Ménard,et al.  Crystal structure of wild‐type human procathepsin K , 1999, Protein science : a publication of the Protein Society.

[128]  J. Pelletier,et al.  Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblasts. , 2009, Bone.

[129]  D. D’Lima,et al.  Caspase inhibitors reduce severity of cartilage lesions in experimental osteoarthritis. , 2006, Arthritis and rheumatism.

[130]  T E Cawston,et al.  Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways. , 2001, Arthritis and rheumatism.

[131]  C. Georgopoulos,et al.  Sequence analysis and regulation of the htrA gene of Escherichia coli: a sigma 32-independent mechanism of heat-inducible transcription. , 1988, Nucleic acids research.

[132]  C. Little,et al.  Differential Expression of Aggrecanase and Matrix Metalloproteinase Activity in Chondrocytes Isolated from Bovine and Porcine Articular Cartilage* , 1998, The Journal of Biological Chemistry.

[133]  B. Gelb,et al.  Ablation of Cathepsin K Activity in the Young Mouse Causes Hypermineralization of Long Bone and Growth Plates , 2009, Calcified Tissue International.

[134]  D. Eyre,et al.  The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. , 2003, Arthritis and rheumatism.

[135]  R. O’Keefe,et al.  Transcriptional regulation of chondrocyte maturation: potential involvement of transcription factors in OA pathogenesis. , 2005, Molecular aspects of medicine.

[136]  D. Woolley,et al.  Catabolism of intact type VI collagen microfibrils: susceptibility to degradation by serine proteinases. , 1993, Biochemical and biophysical research communications.

[137]  R. Kandel,et al.  Membrane type-1 matrix metalloproteinase is induced following cyclic compression of in vitro grown bovine chondrocytes. , 2007, Osteoarthritis and cartilage.

[138]  A. Tomasselli,et al.  Structural and Inhibition Analysis Reveals the Mechanism of Selectivity of a Series of Aggrecanase Inhibitors , 2009, The Journal of Biological Chemistry.

[139]  Kozo Nakamura,et al.  Transcriptional regulation of endochondral ossification by HIF-2α during skeletal growth and osteoarthritis development , 2010, Nature Medicine.

[140]  S. Kumar,et al.  Protective effects of a cathepsin K inhibitor, SB-553484, in the canine partial medial meniscectomy model of osteoarthritis. , 2009, Osteoarthritis and cartilage.

[141]  D. Piecha,et al.  Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants , 2010, Inflammation Research.

[142]  D. Clemmons,et al.  Complement 1s is the serine protease that cleaves IGFBP-5 in human osteoarthritic joint fluid. , 2009, Osteoarthritis and cartilage.

[143]  D. Brömme,et al.  Human Cathepsin O2, a Matrix Protein-degrading Cysteine Protease Expressed in Osteoclasts , 1996, The Journal of Biological Chemistry.

[144]  H. Kato,et al.  Histone Deacetylase 7 Associates with Hypoxia-inducible Factor 1α and Increases Transcriptional Activity* , 2004, Journal of Biological Chemistry.

[145]  D. Qian,et al.  Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha. , 2006, Cancer research.

[146]  A. Parker,et al.  Expression profiling of metalloproteinases and their inhibitors in cartilage. , 2004, Arthritis and rheumatism.

[147]  John M. Shelton,et al.  Histone Deacetylase 4 Controls Chondrocyte Hypertrophy during Skeletogenesis , 2004, Cell.

[148]  J. Block,et al.  Basic Fibroblast Growth Factor Stimulates Matrix Metalloproteinase-13 via the Molecular Cross-talk between the Mitogen-activated Protein Kinases and Protein Kinase Cδ Pathways in Human Adult Articular Chondrocytes* , 2007, Journal of Biological Chemistry.

[149]  C. L. Murphy,et al.  The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. , 2009, Osteoarthritis and cartilage.

[150]  D. Howell,et al.  Further characterization of a neutral metalloprotease isolated from human articular cartilage. , 1982, Arthritis and rheumatism.

[151]  C. Little,et al.  Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. , 2007, The Journal of clinical investigation.

[152]  Tim Clausen,et al.  The Role of Human HtrA1 in Arthritic Disease* , 2006, Journal of Biological Chemistry.

[153]  H. Ma,et al.  Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. , 2004, Arthritis and rheumatism.

[154]  R. Chen,et al.  Regulation of Hypoxia-Inducible Factor 2α Signaling by the Stress-Responsive Deacetylase Sirtuin 1 , 2009, Science.

[155]  E. Vuorio,et al.  Syndecan‐1 expression is upregulated in degenerating articular cartilage in a transgenic mouse model for osteoarthritis , 2005, Scandinavian journal of rheumatology.

[156]  R. Wynn,et al.  Cloning and Characterization of ADAMTS11, an Aggrecanase from the ADAMTS Family* , 1999, The Journal of Biological Chemistry.

[157]  W. Ferrell,et al.  Protease-activated receptor 2: a novel pathogenic pathway in a murine model of osteoarthritis , 2010, Annals of the rheumatic diseases.

[158]  H. Mankin,et al.  Collagenase and collagenase inhibitors in osteoarthritic and normal cartilage. , 1977, The Journal of clinical investigation.

[159]  D. Griggs,et al.  Proprotein convertase activation of aggrecanases in cartilage in situ. , 2008, Archives of biochemistry and biophysics.

[160]  Gillian Murphy,et al.  Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.

[161]  P. Clegg,et al.  MMP‐mediated collagen breakdown induced by activated protein C in equine cartilage is reduced by corticosteroids , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[162]  山本 慎吾 Calcium-dependent cysteine proteinase (calpain) in human arthritic synovial joints , 1994 .

[163]  E. Vuorio,et al.  Accelerated Turnover of Metaphyseal Trabecular Bone in Mice Overexpressing Cathepsin K , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[164]  R. Khokha,et al.  Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis. , 2005, The American journal of pathology.

[165]  K. Naruse,et al.  Regulation of mechanical stress-induced MMP-13 and ADAMTS-5 expression by RUNX-2 transcriptional factor in SW1353 chondrocyte-like cells. , 2011, Osteoarthritis and cartilage.

[166]  A. Geiser,et al.  Regulation of the human ADAMTS-4 promoter by transcription factors and cytokines. , 2006, Biochemical and biophysical research communications.

[167]  J. Enghild,et al.  Proteolytic Activities of Human ADAMTS-5 , 2007, Journal of Biological Chemistry.

[168]  D. Shaw,et al.  Structure of Human Urokinase Plasminogen Activator in Complex with Its Receptor , 2006, Science.

[169]  David T Felson,et al.  Developments in the clinical understanding of osteoarthritis , 2009, Arthritis research & therapy.

[170]  J. Sandy,et al.  Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components. , 1983, The Biochemical journal.

[171]  Lin Xu,et al.  Attenuation of osteoarthritis progression by reduction of discoidin domain receptor 2 in mice. , 2010, Arthritis and rheumatism.

[172]  W. B. van den Berg,et al.  Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis. , 2003, Osteoarthritis and cartilage.

[173]  H. Kawaguchi,et al.  HIF-2α as a possible therapeutic target of osteoarthritis. , 2010, Osteoarthritis and cartilage.

[174]  A. Dorner,et al.  ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[175]  W. B. van den Berg,et al.  Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. , 2009, Arthritis and rheumatism.

[176]  R. Mason,et al.  Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy. , 2003, Arthritis and rheumatism.

[177]  K. Lee,et al.  Association of TIMP-4 gene polymorphism with the risk of osteoarthritis in the Korean population , 2008, Rheumatology International.

[178]  Harry van Goor,et al.  Adamalysins in biology and disease , 2009, The Journal of pathology.

[179]  B. Olsen,et al.  Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis. , 2007, Arthritis and rheumatism.

[180]  Jennifer L. Harris,et al.  Cellular Localization of Membrane-type Serine Protease 1 and Identification of Protease-activated Receptor-2 and Single-chain Urokinase-type Plasminogen Activator as Substrates* , 2000, The Journal of Biological Chemistry.

[181]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[182]  A. Minami,et al.  Down-regulation of cathepsin K in synovium leads to progression of osteoarthritis in rabbits. , 2009, Arthritis and rheumatism.

[183]  M. Kawaichi,et al.  Expression of mouse HtrA1 serine protease in normal bone and cartilage and its upregulation in joint cartilage damaged by experimental arthritis. , 2005, Bone.

[184]  B. Castner,et al.  A14 INJECTED TIMP-3 PROTECTS CARTILAGE IN A RAT MENISCAL TEAR MODEL , 2006 .

[185]  S. Glasson In vivo osteoarthritis target validation utilizing genetically-modified mice. , 2007, Current drug targets.

[186]  J. Woessner Purification of cathepsin D from cartilage and uterus and its action on the protein-polysaccharide complex of cartilage. , 1973, The Journal of biological chemistry.

[187]  R. Altman,et al.  The action of cathepsin D in human articular cartilage on proteoglycans. , 1973, The Journal of clinical investigation.

[188]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[189]  Eun Jin Lee,et al.  Tumor necrosis factor α-mediated cleavage and inactivation of SirT1 in human osteoarthritic chondrocytes. , 2011, Arthritis and rheumatism.

[190]  J. Buckwalter,et al.  Perspectives on chondrocyte mechanobiology and osteoarthritis. , 2006, Biorheology.

[191]  J. Sandy,et al.  Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo. , 2001, The Biochemical journal.

[192]  G. Murphy,et al.  Degradation of cartilage aggrecan by collagenase‐3 (MMP‐13) , 1996, FEBS letters.

[193]  S. Takeda,et al.  Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. , 2001, Genes & development.

[194]  E. Lavallie,et al.  Glycosaminoglycan-binding properties and aggrecanase activities of truncated ADAMTSs: comparative analyses with ADAMTS-5, -9, -16 and -18. , 2006, Biochimica et biophysica acta.

[195]  D. Edwards,et al.  Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption , 2005, Arthritis research & therapy.

[196]  R. Bronson,et al.  Matrix Metalloproteinase 9 Plays a Key Role in Lyme Arthritis but Not in Dissemination of Borrelia burgdorferi , 2009, Infection and Immunity.

[197]  H. Nagase Activation mechanisms of matrix metalloproteinases. , 1997, Biological chemistry.

[198]  H. Lipkin Where is the ?c? , 1978 .

[199]  H. Sun,et al.  CITED2-mediated Regulation of MMP-1 and MMP-13 in Human Chondrocytes under Flow Shear* , 2003, Journal of Biological Chemistry.

[200]  J. Weidner,et al.  Cell-mediated Catabolism of Aggrecan , 1995, The Journal of Biological Chemistry.

[201]  Z. Werb,et al.  Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. , 2009, Arthritis and rheumatism.

[202]  T. Dalmay,et al.  The cartilage specific microRNA‐140 targets histone deacetylase 4 in mouse cells , 2006, FEBS letters.

[203]  J. Sandy,et al.  Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. , 1991, The Journal of biological chemistry.

[204]  D. Shi,et al.  Replication studies in various ethnic populations do not support the association of the HIF-2α SNP rs17039192 with knee osteoarthritis , 2011, Nature Medicine.

[205]  N. Sang,et al.  Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha. , 2006, The Journal of biological chemistry.

[206]  C. López-Otín,et al.  Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. , 1998, The American journal of pathology.

[207]  M. Rivera-Bermúdez,et al.  Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor. , 2011, Osteoarthritis and cartilage.

[208]  J. V. van Meurs,et al.  Cleavage of aggrecan at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: a pivotal role for stromelysin 1 in matrix metalloproteinase activity. , 1999, Arthritis and rheumatism.

[209]  E. Huff-Lonergan,et al.  Effect of pH and ionic strength on mu- and m-calpain inhibition by calpastatin. , 2005, Journal of animal science.

[210]  Ping Wang,et al.  Proprotein Convertase Furin Interacts with and Cleaves Pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi Network* , 2004, Journal of Biological Chemistry.

[211]  Howard S. An,et al.  Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis. , 2008, Gene.

[212]  Konstantinos N. Malizos,et al.  Integrative MicroRNA and Proteomic Approaches Identify Novel Osteoarthritis Genes and Their Collaborative Metabolic and Inflammatory Networks , 2008, PloS one.

[213]  B. Cravatt,et al.  Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis , 2006, Arthritis research & therapy.

[214]  D. Griggs,et al.  Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. , 2007, Arthritis and rheumatism.

[215]  R. Baron,et al.  Anti‐rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen‐induced arthritis in rodents , 2007, British journal of pharmacology.

[216]  J. Saklatvala,et al.  Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage. , 2008, Arthritis and rheumatism.

[217]  T. Aigner,et al.  Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. , 2002, Arthritis and rheumatism.

[218]  S. Ali,et al.  Characterization of cathepsins in cartilage. , 1967, The Biochemical journal.

[219]  J. Weidner,et al.  Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. , 1997, The Journal of clinical investigation.

[220]  J. Smolen,et al.  Increased expression of discoidin domain receptor 2 is linked to the degree of cartilage damage in human knee joints: a potential role in osteoarthritis pathogenesis. , 2007, Arthritis and rheumatism.

[221]  K. Geoghegan,et al.  Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. , 1996, The Journal of clinical investigation.

[222]  S. Mundlos,et al.  Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.

[223]  M. Seldin,et al.  ADAM-TS5, ADAM-TS6, and ADAM-TS7, Novel Members of a New Family of Zinc Metalloproteases , 1999, The Journal of Biological Chemistry.

[224]  Y. Liu,et al.  Yeast Nuclear Extract Contains Two Major Forms of RNA Polymerase II Mediator Complexes* , 2001, Journal of Biological Chemistry.

[225]  M. Wong,et al.  Cyclic tensile strain and cyclic hydrostatic pressure differentially regulate expression of hypertrophic markers in primary chondrocytes. , 2003, Bone.

[226]  S. Goldring,et al.  Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. , 2002, Arthritis and rheumatism.

[227]  B. Leitinger Molecular Analysis of Collagen Binding by the Human Discoidin Domain Receptors, DDR1 and DDR2 , 2003, The Journal of Biological Chemistry.

[228]  D. Brömme,et al.  Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. , 2000, Biochemistry.

[229]  J. Ward,et al.  MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover , 1999, Cell.

[230]  J. Pelletier,et al.  Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes , 2009, BMC musculoskeletal disorders.

[231]  Y. Taketani,et al.  Hedgehog signaling enhances core-binding factor a1 and receptor activator of nuclear factor-kappaB ligand (RANKL) gene expression in chondrocytes. , 2003, The Journal of endocrinology.

[232]  K. Tanzawa,et al.  Inhibition of ADAMTS4 (aggrecanase‐1) by tissue inhibitors of metalloproteinases (TIMP‐1, 2, 3 and 4) , 2001, FEBS letters.

[233]  K. Shimizu,et al.  G1-G2 aggrecan product that can be generated by M-calpain on truncation at Ala709-Ala710 is present abundantly in human articular cartilage. , 2007, Journal of biochemistry.

[234]  H. Sun,et al.  Matrix metalloproteinase-3 in articular cartilage is upregulated by joint immobilization and suppressed by passive joint motion. , 2010, Matrix biology : journal of the International Society for Matrix Biology.

[235]  J. Pelletier,et al.  Proteinase-activated Receptor-2 Gene Disruption Limits the Effect of Osteoarthritis on Cartilage in Mice: A Novel Target in Joint Degradation , 2011, The Journal of Rheumatology.

[236]  T. Hardingham,et al.  The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. , 1992, The Journal of biological chemistry.

[237]  J. Dingle,et al.  Cathepsin D. Characteristics of immunoinhibition and the confirmation of a role in cartilage breakdown. , 1971, The Biochemical journal.

[238]  J. Pelletier,et al.  The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. , 1996, The Journal of clinical investigation.

[239]  M. James,et al.  Structure-Activity Analysis of Cathepsin K/Chondroitin 4-Sulfate Interactions* , 2010, The Journal of Biological Chemistry.

[240]  B. Olsen,et al.  Activation of the Discoidin Domain Receptor 2 Induces Expression of Matrix Metalloproteinase 13 Associated with Osteoarthritis in Mice*♦ , 2005, Journal of Biological Chemistry.

[241]  内藤 智子,et al.  Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage , 2009 .

[242]  I. Shapiro,et al.  Regulation of autophagy in human and murine cartilage: hypoxia-inducible factor 2 suppresses chondrocyte autophagy. , 2009, Arthritis and rheumatism.

[243]  D. Zukor,et al.  Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. , 2005, Arthritis and rheumatism.

[244]  Chi-Huey Wong,et al.  Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways , 2010, Proceedings of the National Academy of Sciences.